-
Professor Ying Yuan: Updates to the 2024 CSCO Guidelines for Colorectal Cancer – Enhancing Personalized Treatment from Pathology to Therapy
The 2024 update of the Chinese Society of Clinical Oncology (CSCO) Guidelines for the Diagnosis and Treatment of Colorectal Cancer has been released. The new edition incorporates the latest evidence-based medical developments, adds new biomarkers for colorectal cancer, enriches clinical treatment strategy options, and adjusts the recommendation levels for various treatment protocols. Oncology Frontier interviewed…
-
EAU24 Expert Commentary | Professor Fufu Zheng: NMIBC Postoperative Intravesical Therapy Strategies and Research Progress
Transurethral resection of bladder tumor (TURBt) is the primary treatment for non-muscle-invasive bladder cancer (NMIBC), but the postoperative tumor recurrence rate remains high, posing a significant clinical challenge. To prevent tumor recurrence, different intravesical therapies are administered post-TURBt based on the patient’s recurrence risk level. At the 2024 39th Annual European Association of Urology (EAU24)…
-
Hepatol Int丨Long-term Prognosis of Robotic Liver Resection for Hepatocellular Carcinoma is Safe and Effective
Primary liver cancer (PLC) is one of the most common cancers worldwide and a leading cause of cancer-related deaths, with hepatocellular carcinoma (HCC) accounting for about 85% of all PLC cases. Despite continuous advancements in medical technology, radical surgical resection of the primary tumor remains a key component of HCC treatment. Robotic liver resection (RLR)…
-
Professor Jun Zhu: Rapid Advances in Clinical Trials Usher in a New Era for Lymphoma Diagnosis and Treatment! | 2024 Nanjing Lymphoma Forum
Amidst the gentle breeze of early summer, the annual “Nanjing Lymphoma Forum” was grandly held in the historic city of Nanjing. This offline event gathered renowned experts in the field of lymphoma from both domestic and international spheres. Through lectures, case discussions, and other formats, the forum facilitated exchanges on the latest achievements and developments…
-
EAU24 On-Site Highlights | Professor Wei Zhai: Advances in Urological Tumor Research to Improve Patient Prognosis
The 39th Annual European Association of Urology (EAU24) Congress took place from April 5-8, 2024, in Paris, France, focusing on global urological oncology hotspots and the forefront of Chinese urological research. At the event, “Oncology Frontier” invited Professor Wei Zhai from Renji Hospital, affiliated with Shanghai Jiao Tong University School o,(f Medicine, to share his…
-
2024 North-South Summit丨Professor Leiping Wang: Is Neoadjuvant Immunotherapy the Future for HR+/HER2- Breast Cancer?
HR+/HER2- is the most common subtype of breast cancer, which is not highly sensitive to neoadjuvant therapy. In 2023, clinical trial results from KEYNOTE-756, CheckMate 7FL, and other studies presented at international conferences showed the potential of neoadjuvant immunotherapy for early-stage HR+/HER2- breast cancer patients. At the 2024 North-South Summit, Professor Leiping Wang from Fudan…
-
2024 North-South Summit丨Professor Jia Wang: Should Contralateral Prophylactic Mastectomy Be Considered for gBRCA-Mutated Breast Cancer?
Among breast cancer patients, 5% to 10% have definite genetic mutations, with gBRCA1/2 mutations accounting for 15% of these cases. Individuals with gBRCA1 mutations have a higher risk of contralateral breast cancer recurrence, making the decision to undergo contralateral prophylactic mastectomy (CPM) a hot topic of discussion. At the 2024 North-South Summit, Professor Jia Wang…
-
Professor Ting Luo: Feasibility of Sequential ADC Treatment in Advanced Breast Cancer: ADC After ADC?丨2024 North-South Meeting
With the continuous development and market release of new ADC drugs, the treatment landscape for breast cancer patients has changed. For patients with advanced breast cancer, the feasibility of using another ADC drug after the initial ADC treatment has become a common clinical concern. In the “In-depth Inquiry” segment of the 2024 North-South Meeting, Professor…
Connecting Medical Expertise through Media